Douglas Wight
Keine laufenden Positionen mehr
Profil
Douglas Wight worked as a Senior Director of Drug Development at MDS Pharma Services (Canada) and as a Senior Director at Celerion, Inc. He then worked as a Vice President of Drug Development at Milestone Pharmaceuticals, Inc. He also worked as a Clinical Research Associate at Sandoz Canada, Inc. and as a Manager of Clinical Research at Searle Canada, Inc. Wight received an undergraduate degree from Concordia University in 1979 and a graduate degree from McGill University in 1981.
Ehemalige bekannte Positionen von Douglas Wight
| Unternehmen | Position | Ende |
|---|---|---|
| MILESTONE PHARMACEUTICALS INC. | Corporate Officer/Principal | 01.12.2021 |
Celerion, Inc.
 Celerion, Inc. Miscellaneous Commercial ServicesCommercial Services Celerion, Inc. provides clinical research solutions and applied translational medicine. Its services include global clinical research, clinical pharmacology sciences, global bioanalytical services, and drug development services. The company was founded in 2010 and is headquartered in Lincoln, NE. | Direktor/Vorstandsmitglied | 01.06.2011 |
MDS Pharma Services (Canada)
 MDS Pharma Services (Canada) Miscellaneous Commercial ServicesCommercial Services MDS Pharma Services provides contract drug discovery and drug development services for pharmaceutical and biotechnology companies. It provides its clients with early-stage, clinical research and late-stage drug discovery and development services, such as Phase I-IV testing, target discovery and lead optimization. The company is located in Saint-Laurent, Canada. | Corporate Officer/Principal | - |
| Searle Canada, Inc. | Corporate Officer/Principal | - |
Sandoz Canada, Inc.
 Sandoz Canada, Inc. Pharmaceuticals: MajorHealth Technology Sandoz Canada, Inc. develops, manufactures, and distributes injections and ophthalmic pharmaceutical products for the hospital and retail markets. It offers ampoules, vials ophthalmic solutions, suspensions and ointments, and suppositories. The company was founded in 1973 and is headquartered in Boucherville, Canada. | Corporate Officer/Principal | - |
Ausbildung von Douglas Wight
| McGill University | Graduate Degree |
| Concordia University | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| MILESTONE PHARMACEUTICALS INC. | Health Technology |
| Private Unternehmen | 4 |
|---|---|
Sandoz Canada, Inc.
Sandoz Canada, Inc. Pharmaceuticals: MajorHealth Technology Sandoz Canada, Inc. develops, manufactures, and distributes injections and ophthalmic pharmaceutical products for the hospital and retail markets. It offers ampoules, vials ophthalmic solutions, suspensions and ointments, and suppositories. The company was founded in 1973 and is headquartered in Boucherville, Canada. | Health Technology |
| Searle Canada, Inc. | |
MDS Pharma Services (Canada)
MDS Pharma Services (Canada) Miscellaneous Commercial ServicesCommercial Services MDS Pharma Services provides contract drug discovery and drug development services for pharmaceutical and biotechnology companies. It provides its clients with early-stage, clinical research and late-stage drug discovery and development services, such as Phase I-IV testing, target discovery and lead optimization. The company is located in Saint-Laurent, Canada. | Commercial Services |
Celerion, Inc.
Celerion, Inc. Miscellaneous Commercial ServicesCommercial Services Celerion, Inc. provides clinical research solutions and applied translational medicine. Its services include global clinical research, clinical pharmacology sciences, global bioanalytical services, and drug development services. The company was founded in 2010 and is headquartered in Lincoln, NE. | Commercial Services |
